
Merck's Capvaxive Pneumococcal Vaccine: EU Approval Progress and Global Access
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of Capvaxive (Pneumococcal 21-valent Conjugate Vaccine) for adults 18 and older to prevent invasive disease and pneumonia caused by …